AstraZeneca’s asthma drug gets regulator’s approval in China
China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.
Drugs
Health
Pharma
China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.